Food Effect Study of D-0502 Tablet in Healthy Volunteers
A Phase I, Randomized, Open Label, Two-Sequence, Two-Period Crossover Study to Evaluate the Effect of Food on the Pharmacokinetics of D-0502 Tablet in Postmenopausal Female Healthy Subjects
Sponsor: InventisBio Co., Ltd
A PHASE1 clinical study on Breast Cancer, this trial is completed. The trial is conducted by InventisBio Co., Ltd and has accumulated 7 data snapshots since 2018. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
7 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jan 2022 — Jul 2024 [monthly]
Completed PHASE1
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE1
-
Sep 2019 — Jan 2021 [monthly]
Completed PHASE1
Status: Active Not Recruiting → Completed
▶ Show 2 earlier versions
-
May 2019 — Sep 2019 [monthly]
Active Not Recruiting PHASE1
-
Feb 2019 — May 2019 [monthly]
Active Not Recruiting PHASE1
First recorded
Oct 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- InventisBio Co., Ltd
For direct contact, visit the study record on ClinicalTrials.gov .